Overexpression of Glyoxalase 2 in Human Breast Cancer Cells: Implications for Cell Proliferation and Doxorubicin Resistance
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252010888 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Brenda Romaldi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica delle Marche, 60131 Ancona, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Cell Proliferation, Doxorubicin, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glyoxalase 2 (Glo2) is an enzyme of the glyoxalase system whose pathway parallels glycolysis and which aims to remove methylglyoxal (MGO). This study analyzed the possible additional roles of the Glo2 enzyme in breast cancer (MCF7) and non-cancer (HDF) cell lines, investigating its presence at the nuclear level and its potential involvement in cell proliferation and chemotherapy resistance. The results revealed that Glo2 is overexpressed in cancer cells, and its expression is higher during the proliferative (S and G2/M) phases of the cell cycle. The study also examined a post-translational modification (PTM) in which Glo2 could be involved, with S-glutathionylation revealing that Glo2 enhances this PTM in cancer cells both in the cytoplasm and nucleus. Inhibition of Glo2 by p-NCBG resulted in increased sensitivity to doxorubicin, a common chemotherapeutic agent. This suggests that Glo2 increases cancer cell resistance to chemotherapy, potentially through its role in regulating oxidative stress. These results highlight Glo2 as a potential therapeutic target to improve the efficacy of existing treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica delle Marche, 60131 Ancona, Italy.
- Department of Life and Environmental Sciences, Università Politecnica delle Marche, 60131 Ancona, Italy.
- Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), National Research Council (CNR), 70126 Bari, Italy.
- Department of Medicine and Surgery, Università degli Studi di Perugia, 06129 Perugia, Italy.
- Department of Physiology, Medicine and Dentistry School, University of Valencia-INCLIVA, Center for Biomedical Network Research on Rare Diseases (CIBERER), 46010 Valencia, Spain.
ORCID-Profile: Andrea Scirè, Cristina Minnelli, Andrea Frontini, Laura Cianfruglia, Giovanna Mobbili, Lidia de Bari, Cinzia Antognelli, Federico V Pallardó, Tatiana Armeni
Zitieren
APA
Romaldi, B., Scirè, A., Minnelli, C., Frontini, A., Casari, G., Cianfruglia, L., Mobbili, G., de Bari, L., Antognelli, C., Pallardó, F. V., & Armeni, T. (2024). Overexpression of Glyoxalase 2 in Human Breast Cancer Cells: Implications for Cell Proliferation and Doxorubicin Resistance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252010888
Vancouver
Romaldi B, Scirè A, Minnelli C, Frontini A, Casari G, Cianfruglia L, et al. Overexpression of Glyoxalase 2 in Human Breast Cancer Cells: Implications for Cell Proliferation and Doxorubicin Resistance. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252010888
BibTeX
@article{Romaldi2024,
author = {Romaldi, Brenda and Scirè, Andrea and Minnelli, Cristina and Frontini, Andrea and Casari, Giulia and Cianfruglia, Laura and Mobbili, Giovanna and de Bari, Lidia and Antognelli, Cinzia and Pallardó, Federico V and Armeni, Tatiana},
title = {Overexpression of Glyoxalase 2 in Human Breast Cancer Cells: Implications for Cell Proliferation and Doxorubicin Resistance},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252010888}
}
EUVIMED